Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Five Prime Therapeutics. United States. Announced Date 04/03/2021. Closed Date 16/04/2021. Deal value: $1900m. Amgen to acquire Five Prime Therapeutics. Industry: Five Prime Therapeutics is a biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics.

Back to Search Contact Business